A little-known mouse protein disrupts cancer-causing chemical changes to genes associated with human colorectal cancer cells and potentially could be used to treat solid tumors, according to a new ...
Biocytogen (HKEX: 02315), a global biotech company dedicated to discovering and developing novel antibody therapeutics, announced the licensing of its fully human antibodies to ...
In Canada, colorectal cancer is projected to be the fourth most commonly diagnosed cancer in 2024 (excluding non-melanoma skin cancers), according to the Canadian Cancer Society.
Colon cancer symptoms in women include diarrhea, constipation, unintended weight loss, and bloody stools. While these are the same for anyone with colon cancer, symptoms in women may be misattributed ...
That would be opening the door to a new pandemic for sure.” For that to happen, the H5N1 virus would have to develop the right mutations that allow it to more easily infect human cells—a ...
Colorectal cancer (CRC) is stratified into four consensus molecular subtypes (CMS1-4) but their distinct molecular profiles remain to be understood. Here the authors model the CRC subtypes with ...
Background Aberrant Wnt pathway activation is a key driver of colorectal cancer (CRC) and is essential to sustain tumour growth and progression. Although the downstream protein-coding target genes of ...
A collaborative research effort led by Indian Institute of Technology Guwahati and Bose Institute Kolkata has resulted in the development of an injectable hydrogel for targeted cancer treatment. The ...